AYTU BioPharma
AYTU
AYTU
50 hedge funds and large institutions have $26.1M invested in AYTU BioPharma in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
46% less capital invested
Capital invested by funds: $48.3M → $26.1M (-$22.2M)
58% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 24
Holders
50
Holding in Top 10
–
Calls
$1.37M
Puts
$808K
Top Buyers
| 1 | +$2.21M | |
| 2 | +$1.74M | |
| 3 | +$510K | |
| 4 |
D.E. Shaw & Co
New York
|
+$480K |
| 5 |
E
Ergoteles
New York
|
+$378K |
Top Sellers
| 1 | -$5.54M | |
| 2 | -$2.76M | |
| 3 | -$2.1M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$833K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$702K |